Status:
COMPLETED
Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery
Lead Sponsor:
Pfizer
Conditions:
Pain
Hallux Valgus
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect ...
Eligibility Criteria
Inclusion
- Patients who underwent an uncomplicated primary unilateral first metatarsal bunionectomy surgery (with or without ipsilateral hammer toe repair) who required open manipulation of bone with periosteal evaluation under general anesthesia (Mayo block)
- Patients with a baseline pain intensity (VAS) of greater than or equal to 45 mm
- Patients with a baseline pain intensity (categorical) of moderate or severe
Exclusion
- Patients scheduled to undergo other surgical procedures that would be expected to produce a greater degree of surgical trauma than the orthopedic procedure alone
- Treatment with patient-controlled analgesia (PCA) subsequent to the end of anesthesia
- Long-acting local anesthetics or local anesthetics coadministered with epinephrine injected into the index joint space
- Use of tricyclic antidepressants, tranquilizers, neuroleptics, neuroleptic antiemetics, COX-2 inhibitors, NSAIDs, and corticosteroids
- Use of NSAID or analgesia after midnight the night prior to surgery or unwilling to abstain from NSAIDs or other analgesics, except as specified in the protocol, during the study
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2003
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00683137
Start Date
October 1 2002
End Date
February 1 2003
Last Update
May 23 2008
Active Locations (89)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chandler, Arizona, United States, 85224
2
Pfizer Investigational Site
Glendale, Arizona, United States, 85302
3
Pfizer Investigational Site
Glendale, Arizona, United States, 85306
4
Pfizer Investigational Site
Mesa, Arizona, United States, 85204